Clover Biopharmaceuticals, Ltd announced that it will receive $320,713 in funding on April 2, 2024. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.365 HKD | 0.00% |
|
-3.95% | -41.13% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.13% | 60.66M | |
+16.73% | 121B | |
+21.13% | 114B | |
+18.05% | 23.61B | |
-17.94% | 20.43B | |
-16.24% | 16.55B | |
-11.76% | 16.45B | |
-44.45% | 15.59B | |
+69.92% | 15.19B | |
+1.41% | 13.54B |
- Stock Market
- Equities
- 2197 Stock
- News Clover Biopharmaceuticals, Ltd.
- Clover Biopharmaceuticals, Ltd. announced that it expects to receive $0.320713 million in funding